The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years
Panel supports research to distinguish between types of chronic inflammatory airway disease including asthma, COPD and IPF
The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs
Precision dosing of the liquid therapy is very important as it must correspond to each patient’s addiction level
These findings are crucial as rapidly spreading variants of SARS-CoV-2 have been reported in various countries
Working with the UK government, first vaccinations are to begin early in the new year
Take a look back at the technologies, innovations and clinical advances that hit the headlines over the past 12 months
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein
Explore ways to improve time to result in critical pathways such as sepsis
HALIX to provide large-scale GMP manufacture of AZD1222
In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.
Two different dosing regimens demonstrated efficacy with one showing a better profile
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported
Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing
QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes
Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide
Collaboration to develop next-generation CAR-T cell therapies with improved efficacy and durability
The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR
